Swisher Hygiene Inc. Message Board
-
I agree that the SP range at $9 is good..but I think the real truth lies at the foot of the next company to prove a stem cell benifit for SOC that is more real than DNDN Provenge..is likely to see some crazy share appreciation..who knows who that will be is the real question..I'll take the $9..GLTA
Sentiment: Buy
-
Lots of news out..London Times, Citibank projects 35 billion in sales and treatment of 60% of all cancers and other health concerns..CNBC touched briefly..I'd say this much positive news this quick will shed a nice light on all stem cell, regenerative therapies..will see..
-
Insider buying further confirmation of pending news ..expect to see Marty and others buying now before news..MHO
Sentiment: Buy
-
Evs..exactly. My opinion is that the strike price is a deal..but like I said..there are 3 possibilities..the question was what do you think the option price tells us..like a point spread line..if you like you buy..me..I have my shares at an av cost of $1.04 and cashed out huge between $3.50 and $3.72..be assured that if we approach July in this range I will double up..time is on our side since January..tick tock..tick tock..me likey.
Sentiment: Buy
-
I have said this recently..I will say it again..management expects to get the first if not both deals done shortly..this will impact share price. The hope there is that the share price will have risen enough to make RS a stable proposition and at a lower share rate. That being said I would expect news before month end..if not then certainly in June. There will not be a RS until after this news. There will be a significant SP increase before that time..MHO..GLTA
Sentiment: Buy
-
Yeah..I think it indicates that If the interim data does not come out we will be in this SP range in July..Besides the obvious other two results..up or down..
Sentiment: Buy
-
Further confirmation of science will result in at least a minimum 100% appreciation of SP..MHO
Sentiment: Buy
-
Why..why..why
Sentiment: Buy
-
...Cmxi will not do the RS until they get the pending partnership deal signed. So figure the share price goes to $1.00 on this news. RS then could be 3/1, 4/1 or 5/1. I think the company see's this scenario..higher share price lower RS. MHO.
Sentiment: Buy
-
I agree with koko..the way we got here is that the first partnership deal played out..turns out poorly in terms of perception. When we hit the 2.32 LY the expectation was the deal was done and uplisting would occur naturally..bad call..now since then we have stacked mucho lumber, approvals, new indications..much good news..the share price has not reflected these positives..The RS along with a rapidly improving balance sheet..one possible 2 deals this year (heavy lifting/marketing) WILL get institutional investors on the boat..MHO. GLTA..Remember we have 2 sturdy legs on the 3 leg stool..
Sentiment: Buy
-
Agreed..I think thats why Singh is gone..He owned his shares and I believe was pushing for a buy out..Yu shot him for that ultimately..So looking at Singhs shares he has not sold any..so can you assume he has an idea about the trial..instictually if you will?
- Reply to
You can't have 64 events in December and not have manufacturing issues
by discoduck33 •May 15, 2013 12:52 PMI will be whipped if there is any difference of efficay in the two production facilities. I think that to be a nonissue..MHO
Sentiment: Buy
-
Can anyone shed light on why Yu only has 10,000 shares on record. ?
- Reply to
Calculating the current p-value as it stands right now
by discoduck33 •May 10, 2013 2:51 PMKey statement Duck..this is where my heads at. "Now, of course, that is just the p-value of 32 events. The p-value should go down each day, if the same survival curve maintains itself. We should be also able to calculate the p-value at 64 events, assuming we have the same survival rates. " Its a fact jack...GLTA
Sentiment: Buy
-
Unless you really want to sell I would be careful with limit orders today.
Sentiment: Buy
-
It will be a good study for 2013 where revenues for PCT go. MHO..GLTA
Sentiment: Buy
- Reply to
Now everyones knos why IMUC has not and will not get above $3!!!!!!
by hippocampus48 •May 11, 2013 10:52 AMTotally 100% disagree. If the effacy is proven and runs circles around current SOC..we will see an uptick to 10 to 20. Think about DNDN.FDA has options and no one is going to think twice about helping this patient group..especially when there is no contraindications...MHO..GLTA.
Sentiment: Buy
-
I would agree . The elaboration by Marty was well timed. He got his #$%$ kicked last year after CMS approval. I am over it as anyone could have misjudged what happened after the top 20 deal fell thru. Now he made it crystal clear..A partner for Angel to promote and manage (out of house) and a partner for Autogel help promote and mange(in house). Yes I think one of these deals is nearly done. MHO..GLTA
Sentiment: Buy
- Reply to
We don't need 300 HLA-A1 and HLA-A2 patients for approval (or a Phase III)
by discoduck33 •May 9, 2013 10:13 PMNo doubt why Dr. Yu choose GBM..1. It is a horrible type of cancer. 2. Results will speak volumes about the the future of the science..MHO..Stem cell therapies are the new space program.GLTA
Sentiment: Buy
-
Revenue is revenue..You can't grow a forest without planting a tree.
Sentiment: Buy